Report: Global Marijuana Infused Products Market Valued at $30 Billion, to Grow to $150 Billion by 2030

A new report by Data Bridge Market Research states that the global marijuana infused products market is currently valued at almost $30 billion, and is expected to see rapid growth in the coming years.

marijuana infused products market

In the report Data Bridge Market Research predicts that the cannabis infused products market which was $29.68 billion in 2022, would rocket up to $150.51 billion by 2030, and is expected to undergo a compound annual growth rate (CAGR) of 22.5% during the forecast period 2023 to 2030.

“Cannabis is increasingly recognized as an effective treatment for many conditions, including nausea and vomiting brought by chemotherapy, restlessness, muscle tightness, and chronic discomfort”, states the report, pointing out some of the key drivers of market growth. “CBD and THC-infused edibles are becoming increasingly popular in all legal states. Furthermore, customers and investors are becoming more interested in infused beverages.”
Continue reading

Marijuana Becomes Legal in Luxembourg on July 21

Last month Luxembourg’s Parliament passed legislation to make their country just the second in the European Union to legalize marijuana possession and cultivation. On July 21 the law takes effect.

“On July 17, 2023 the law amending the amended law of February 19, 1973 concerning the sale of medicinal substances and the fight against drug addiction, providing for the legalization of the domestic cultivation of cannabis under certain conditions, has been published in the Official Journal”, said the country’s Ministry of Health. “It will enter into force on the fourth day following the day of its publication, i.e. Friday, July 21, 2023.”

The Chamber of Deputies voted 38 to 22 last month to pass the bill that has been in the works for years. On July 21 Luxembourg will join Malta as the only European Union countries with legal recreational marijuana.
Continue reading

Ukraine Parliament Votes 268 to 137 to Legalize Medical Marijuana

Ukraine’s Verkhovna Rada (Parliament) has passed legislation to legalize medical marijuana through its first reading.

The measure received a 268 to 137 vote in the parliament. It will need to be passed through one more reading before it can be sent to President Volodymyr Zelenskyy for consideration. President Zelenskyy is in support of the law and says he’ll quicky sign it into law if it reaches his desk.

The measure has been stalled in the parliament for around two years, but gained momentum earlier this year as Zelenksyy increased calls for medical marijuana legalization.
Continue reading

Ohio Adds Irritable Bowel Syndrome to List of Medical Marijuana Conditions

Ohio officials have officially expanded the state’s list of medical conditions that qualify an individual to become a legal medical marijuana patient.

The State Medical Board of Ohio voted recently to add irritable bowel syndrome (IBS) to the state’s medical marijuana program. Proponents of the change noted that 10% to 15% of US adults have IBS, with multiple peer-reviewed studies indicating that marijuana and its compounds may help treat the ailment or at least improve its symptoms.

The board rejected proposals that would have also added autism spectrum disorder and obsessive-compulsive disorder to the list of qualifying conditions.
Continue reading

Study: Dystonia Patients Saw “Significant Subjective Improvement” From Marijuana Use

In a new study “Dystonia patients who use medical cannabis under clinical observation reported significant subjective improvement during 30 months of use in average.”

The study is titled A single-center real-life study on the use of medical cannabis in patients with dystonia. It was published in the recent issue of the journal Frontiers in Neurology, and it was conducted by researchers from Tel Aviv University, the University of London, Chaim Sheba Medical Center and Bar-Ilan University, all in Israel.

“While cannabis-based medicine is being commonly used in patients with movement disorders, there is a scarcity of publications regarding the effect of cannabis on dystonia”, states the study’s abstract. “We aimed to describe medical cannabis use in patients with dystonia and related pain.”
Continue reading

Study: CBD Reduces Seizure Frequency and May Have a “Wide Range of Beneficial Effects”

A new study published by the Journal of Child Neurology has found that “in addition to reduced seizure frequency, CBD may have a wide range of beneficial effects beyond seizure control that warrant further investigation.”

The objective of the study was to “increase understanding of the impact of cannabidiol (CBD) on outcomes beyond seizure control among individuals with Dravet syndrome or Lennox-Gastaut syndrome.”

Qualitative interviews were conducted with caregivers of individuals with Dravet syndrome or Lennox-Gastaut syndrome treated with plant-derived, highly purified CBD medicine (Epidiolex in the USA; Epidyolex in Europe; 100 mg/mL oral solution). Symptoms and impacts of Dravet syndrome and Lennox-Gastaut syndrome on individuals were explored, as were the effects of CBD. Data were analyzed using thematic analysis.
Continue reading

Idaho Group Aims to Put Medical Marijuana Initiative on 2024 Ballot

A group called Kind Idaho is working to put their medical marijuana legalization initiative to a vote of the people in 2024.

Kind Idaho’s initiative would legalize medical marijuana for those with a qualifying condition who receive a recommendation from a physician. The possession limit would be set at four ounces, with patients allowed to grow up to six plants for personal use. The initiative would also establish a licensed and regulated system of medical marijuana dispensaries.

The initiative campaign is funded in part by the Marijuana Policy Project, a group that has led successful initiatives to legalize medical and recreational marijuana in numerous states. The language of Kind Idaho’s initiative is identical the initiative proposed by Idaho Citizens Coalition in 2020 and 2022 (the Coalition “gifted” the initiative to Kind Idaho so they could lead the new effort).
Continue reading

North Carolina Tribe May Legalize Recreational Marijuana, Open Medical Marijuana Superstore to All

The Eastern Band of Cherokee Indians (EBCI) will soon vote on whether or not to legalize recreational marijuana for everyone 21 and older.

The EBCI, located on 57,000 acres in the western part North Carolina, legalized medical marijuana in 2021. The tribe recently began accepting applications for those wanting to become patients for their soon-to-open medical marijuana superstore, which is a refurbished bingo hall the tribe spent $50 million to renovate. At the moment the application process is open to anyone 18 and older, regardless of whether or not they’re a member of the tribe. Although a person applying would need to have one of around 20 medical conditions, no doctor’s recommendation is required.

The requirement to have a medical condition may soon vanish, with the EBCI Tribal Council voting to place a referendum on the September 7 general election ballot that would legalize recreational marijuana for everyone 21 and older, with no requirement to be a member of the EBCI.
Continue reading

Michigan: Record-Breaking $260 Million in Legal Marijuana Sold in June

There was over a quarter billion dollars in legal marijuana sold in June in Michigan, a new monthly record.

Michigan marijuana sales reached $260.8 million in June, the highest single-month of legal marijuana sales in the state’s history. This marks a 6% increase from the total sales in May, and an almost 40% increase from June, 2022.

Of the $260 million in legal marijuana sold, just $6.6 million was purchased by medical marijuana patients, with the remaining $254 million sold to recreational consumers.
Continue reading

Study: Marijuana Enhances Runner’s High

According to a new study marijuana use prior to running is associated with greater feelings of enjoyment and tranquility.

The study is titled Running High: Cannabis Users’ Subjective Experience of Exercise During Legal Market Cannabis Use Versus No Use in a Naturalistic Setting, and is published in the journal Cannabis and Cannabinoid Research. The study was also published online by the US National Library of Medicine, and it was conducted by researchers at University of Colorado’s Department of Psychology and Neuroscience.

“The use of cannabis with various forms of exercise (e.g., running) has received increased media attention in recent years, contradicting the popular stereotype that cannabis is associated with sedentary behavior”, states the study’s abstract. “Although cross-sectional evidence suggests a positive association between cannabis use and exercise engagement, to date, the acute effects of cannabis on exercise remain unclear.”
Continue reading